These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 1238327

  • 21. Pharmacological profile of a new beta-adrenoceptor blocker, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696).
    Nakagawa Y, Sugai T, Chin WP, Shibuya T, Hashimoto K, Imai S.
    Arzneimittelforschung; 1984; 34(2):194-9. PubMed ID: 6144313
    [Abstract] [Full Text] [Related]

  • 22. Hypotensive action of an aqueous extract of Pimenta dioica (Myrtaceae) in rats.
    Suárez A, Ulate G, Ciccio JF.
    Rev Biol Trop; 2000 Mar; 48(1):53-8. PubMed ID: 11021313
    [Abstract] [Full Text] [Related]

  • 23. [Effects of the anti-ulcer drug SU-88 on the gastric blood flow and the cardiovascular system (author's transl)].
    Saziki R, Arai I, Isobe Y, Aihara H.
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):193-202. PubMed ID: 7084818
    [Abstract] [Full Text] [Related]

  • 24. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E, Murai T, Ishizaka Y, Sanai K.
    Arzneimittelforschung; 1984 Mar; 34(11A):1641-51. PubMed ID: 6152157
    [Abstract] [Full Text] [Related]

  • 25. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M, Yajima M, Nishimura T, Ikeda H, Nishimori T.
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [Abstract] [Full Text] [Related]

  • 26. [Effects of oxybutynin on the cardiovascular system in dogs].
    Misawa M, Hosokawa T, Kamei J, Yanaura S, Fujii Y, Watanabe K, Uehara M, Kasama T.
    Nihon Yakurigaku Zasshi; 1984 Oct; 84(4):395-406. PubMed ID: 6510843
    [Abstract] [Full Text] [Related]

  • 27. Effects of brotizolam on cardiovascular functions and autonomic nervous system.
    Kushiku K, Morishita H, Furukawa T, Kitagawa H, Ueno K, Kitagawa H, Kohei H.
    Arzneimittelforschung; 1986 Mar; 36(3A):552-9. PubMed ID: 3718577
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. III. Action on the secretions of the digestive tract and on the central nervous system, acute toxicity.
    Cosnier D, Hache J, Labrid C, Streichenberger G.
    Arzneimittelforschung; 1975 Mar; 25(12):1926-33. PubMed ID: 3186
    [Abstract] [Full Text] [Related]

  • 30. Analysis of the cardiovascular effects of co-derocrine (Hydergine).
    Clark BJ, Bucher T, Waite R.
    J Pharmacol; 1985 Mar; 16 Suppl 3():101-11. PubMed ID: 2869189
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Mechanisms underlying the cardiovascular effects of a labdenic diterpene isolated from Moldenhawera nutans in normotensive rats.
    Lahlou S, de Barros Correia CA, Vasconcelos Dos Santos M, David JM, David JP, Duarte GP, Magalhães PJ.
    Vascul Pharmacol; 2007 Jan; 46(1):60-6. PubMed ID: 16875882
    [Abstract] [Full Text] [Related]

  • 33. General pharmacology of the anxiolytic compound metaclazepam in comparison to other benzodiazepines.
    Buschmann G, Kühl UG, Rohte O.
    Arzneimittelforschung; 1985 Jan; 35(11):1643-55. PubMed ID: 2868732
    [Abstract] [Full Text] [Related]

  • 34. On the mechanism of the hypotensive action of urapidil.
    Bousquet P, Feldman J, Schwartz J.
    J Hypertens Suppl; 1985 Dec; 3(3):S187-9. PubMed ID: 2856701
    [Abstract] [Full Text] [Related]

  • 35. [Pharmacological action of [ethyl p(6-guanidinohexanoyloxy)benzoate] methanesulfonate (FOY)].
    Okegawa T, Aishita H, Akimoto A, Makita T, Nakai H.
    Nihon Yakurigaku Zasshi; 1975 Jan; 71(1):71-87. PubMed ID: 239887
    [Abstract] [Full Text] [Related]

  • 36. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT, Levy GP.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [Abstract] [Full Text] [Related]

  • 37. General pharmacology of the new quinolone antibacterial agent levofloxacin.
    Takasuna K, Kasai Y, Usui C, Takahashi M, Hirohashi M, Tamura K, Takayama S.
    Arzneimittelforschung; 1992 Mar; 43(3A):408-18. PubMed ID: 1622443
    [Abstract] [Full Text] [Related]

  • 38. Cardiovascular pharmacology of ASL-7022. III. Peripheral vascular adrenergic mechanisms.
    Gorczynski RJ, Reynolds RD.
    J Pharmacol Exp Ther; 1985 Mar; 232(3):629-35. PubMed ID: 2857783
    [Abstract] [Full Text] [Related]

  • 39. Chemico-pharmacological studies on saponins of Panax ginseng C. A. Meyer. II. Pharmacological part.
    Kaku T, Miyata T, Uruno T, Sako I, Kinoshita A.
    Arzneimittelforschung; 1975 Apr; 25(4):539-47. PubMed ID: 239732
    [Abstract] [Full Text] [Related]

  • 40. [Effects of guanabenz on the cardiovascular system, in comparison with clonidine and guanethidine].
    Hojo M, Yoshida Y, Nagasaka Y, Machida K, Tatsumi H.
    Nihon Yakurigaku Zasshi; 1983 Jan; 81(1):39-58. PubMed ID: 6852681
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.